PALI

Palisade Bio, Inc. - Common Stock (PALI)

About Palisade Bio, Inc. - Common Stock (PALI)

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.

Details

Daily high
$1.99
Daily low
$1.80
Price at open
$1.98
52 Week High
$2.86
52 Week Low
$0.53
Market cap
333.2M
Dividend yield
0.00%
Volume
3.0M
Avg. volume
4.5M
P/E ratio
-1.34

Palisade Bio, Inc. - Common Stock News

Details

Daily high
$1.99
Daily low
$1.80
Price at open
$1.98
52 Week High
$2.86
52 Week Low
$0.53
Market cap
333.2M
Dividend yield
0.00%
Volume
3.0M
Avg. volume
4.5M
P/E ratio
-1.34